Concurrency | Jotup

Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®

Retrieved on:

fredag, juni 7, 2024

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data on TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), also known in the European Union and in the U.K. as KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor, were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 47th European Cystic Fibrosis Conference held June 5-8, 2024, in Glasgow, Scotland.

Key Points:

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data on TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), also known in the European Union and in the U.K. as KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor, were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 47th European Cystic Fibrosis Conference held June 5-8, 2024, in Glasgow, Scotland.
Data from a randomized, double-blind, Phase 3 study (abstract WS06.04) demonstrated that people with CF who have rare, non-F508del mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene responsive to TRIKAFTA® in vitro demonstrated clinical benefit from receiving TRIKAFTA®.
Safety and tolerability were generally consistent with the established safety profile of TRIKAFTA®.
Ineligible Cohorts in the US Cystic Fibrosis Foundation Patient Registry (CFFPR) During COVID-19”
Abstract P072, entitled “Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Italy: A Retrospective Study From a CF Center”

AREX Capital Management Issues Letter to Enhabit Stockholders Regarding the Need for Dramatic Changes to Board Composition

Retrieved on:

onsdag, maj 29, 2024

We are disappointed that the Board has chosen to continue its pattern of deflecting the valid and serious concerns of its stockholders.

Key Points:

We are disappointed that the Board has chosen to continue its pattern of deflecting the valid and serious concerns of its stockholders.
This dearth of specialized knowledge was exacerbated by a Board that was similarly devoid of relevant operating expertise.
While the Board possessed generally solid résumés, it lacked the industry-specific familiarity to guide a novice management team through industry-specific challenges.
The AREX Slate has a deep understanding of managing payor relationships, and it has a comprehensive grasp of capital markets.

Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting

Retrieved on:

onsdag, maj 29, 2024

Toronto Stock Exchange, Special, Bank statement, AGM, Amalgamation, Concurrency, TSX, TMD

TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “Amending Agreement”), in respect of the previously announced amalgamation agreement dated March 17, 2024 (the “Amalgamation Agreement”) among Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) and Titan, to result in the merger of Conavi and Titan (the “Proposed Transaction”).

Key Points:

TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “Amending Agreement”), in respect of the previously announced amalgamation agreement dated March 17, 2024 (the “Amalgamation Agreement”) among Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) and Titan, to result in the merger of Conavi and Titan (the “Proposed Transaction”).
In addition, Titan announces that the Toronto Stock Exchange (“TSX”) has granted Titan an extension to hold its Annual General and Special Meeting of Shareholders (the “AGM”) on or before July 31, 2024.
As consideration for Titan entering into the Amending Agreement and agreeing to extend the various dates set forth therein, Conavi has agreed to advance $150,000 to Titan as a deposit for direct and incremental expenses Titan may incur as a result of the extension to a maximum of $150,000.
Titan intends to schedule a date for the AGM as soon as practicable and to provide shareholders with the requisite notice of meeting and record date associated therewith.

JD.com Prices Upsized Offering of US$1.75 Billion Convertible Senior Notes

Retrieved on:

tisdag, maj 21, 2024

Hong Kong Stock Exchange, HKD, HKEX, Share repurchase, Stock exchange, RMB, JD.com, Investment, Exercise, Sale, Person, ADS, Regulation, JD, Concurrency, Hand, Security (finance)

The Company has granted an option to the initial purchasers in the Notes Offering, exercisable within a 30-day period, beginning on and including the date of the Notes Offering, to purchase up to an additional US$250 million in aggregate principal amount of the Notes.

Key Points:

The Company has granted an option to the initial purchasers in the Notes Offering, exercisable within a 30-day period, beginning on and including the date of the Notes Offering, to purchase up to an additional US$250 million in aggregate principal amount of the Notes.
The Company expects that potential purchasers of the Notes may employ a convertible arbitrage strategy to hedge their exposure in connection with the Notes.
The Company expects to close the Notes Offering on or about May 23, 2024, subject to the satisfaction of customary closing conditions.
This press release contains information about the pending Notes Offering, and there can be no assurance that the Notes Offering will be completed.

JD.com Announces Proposed Offering of US$1.5 Billion Convertible Senior Notes

Retrieved on:

tisdag, maj 21, 2024

Hong Kong Stock Exchange, HKD, HKEX, Share repurchase, Stock exchange, RMB, JD.com, Investment, Sale, Person, Regulation, JD, Concurrency, Hand, Security (finance)

The Company intends to grant an option to the initial purchasers in the Notes Offering, exercisable within a 30-day period, beginning on and including the date of the Notes Offering, to purchase up to an additional US$225 million in aggregate principal amount of the Notes.

Key Points:

The Company intends to grant an option to the initial purchasers in the Notes Offering, exercisable within a 30-day period, beginning on and including the date of the Notes Offering, to purchase up to an additional US$225 million in aggregate principal amount of the Notes.
The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Notes.
The Company expects that potential purchasers of the Notes may employ a convertible arbitrage strategy to hedge their exposure in connection with the Notes.
This press release contains information about the pending Notes Offering, and there can be no assurance that the Notes Offering will be completed.

Permian Resources Corporation Announces Pricing of Secondary Public Offering of Class A Common Stock

Retrieved on:

måndag, maj 13, 2024

Energy, Other Energy, Oil, Gas, Permian, EnCap Investments, Telephone, Sale, Prospectus, Sales, Common stock, Concurrency, Goldman Sachs, Security (finance)

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the pricing of an underwritten public offering of an aggregate 51,765,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), at a price to the public of $16.47 per share, by certain affiliates of EnCap Investments L.P., NGP Energy Capital Management L.L.C., Pearl Energy Investments, Riverstone Investment Group LLC and a certain member of the Company’s Board of Directors (collectively, the “Selling Stockholders”).

Key Points:

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the pricing of an underwritten public offering of an aggregate 51,765,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), at a price to the public of $16.47 per share, by certain affiliates of EnCap Investments L.P., NGP Energy Capital Management L.L.C., Pearl Energy Investments, Riverstone Investment Group LLC and a certain member of the Company’s Board of Directors (collectively, the “Selling Stockholders”).
Permian Resources will not sell any shares of Class A common stock in the offering and will not receive any proceeds therefrom.
The offering of Class A common stock is not conditioned upon the completion of the Concurrent OpCo Unit Purchase, but the Concurrent OpCo Unit Purchase is conditioned upon the completion of the offering.
The offering is expected to close on May 15, 2024, subject to customary closing conditions.

Permian Resources Corporation Announces Secondary Public Offering of Class A Common Stock

Retrieved on:

måndag, maj 13, 2024

Oil, Gas, Energy, Permian, EnCap Investments, Telephone, Sale, Prospectus, Sales, Common stock, Concurrency, Goldman Sachs, Security (finance)

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the commencement of an underwritten public offering of an aggregate 51,765,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of EnCap Investments L.P., NGP Energy Capital Management L.L.C., Pearl Energy Investments, Riverstone Investment Group LLC and a certain member of the Company’s Board of Directors (collectively, the “Selling Stockholders”).

Key Points:

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the commencement of an underwritten public offering of an aggregate 51,765,000 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of EnCap Investments L.P., NGP Energy Capital Management L.L.C., Pearl Energy Investments, Riverstone Investment Group LLC and a certain member of the Company’s Board of Directors (collectively, the “Selling Stockholders”).
Permian Resources will not sell any shares of Class A common stock in the offering and will not receive any proceeds therefrom.
The offering of Class A common stock is not conditioned upon the completion of the Concurrent OpCo Unit Purchase, but the Concurrent OpCo Unit Purchase is conditioned upon the completion of the offering.
Goldman Sachs & Co. LLC is serving as the underwriter for the offering.

Treasury Metals and Blackwolf Announce Upsize to Concurrent Financing

Retrieved on:

torsdag, maj 9, 2024

Sale, Prospectus, Concurrency, Person, OTCQX, News, Treasury, TSX, Income Tax Act, TML, FF, Gold, Security (finance)

The Concurrent Financing will provide us with 18 months of continued exploration activity.

Key Points:

The Concurrent Financing will provide us with 18 months of continued exploration activity.
Each Warrant will be exercisable at a price of $0.35 for a period of 36 months following the closing of the Concurrent Financing.
The Concurrent Financing is being conducted in all of the provinces and territories of Canada pursuant to applicable prospectus exemptions‎.
Completion of the Concurrent Financing is subject to obtaining the required TSX approvals (including the approval of shareholders) and satisfaction of customary closing conditions.

The Wealth Stewards Aligns with Concurrent

Retrieved on:

torsdag, maj 9, 2024

Consulting, Banking, Professional Services, Finance, Culture, Enterprise, Concurrency, Wealth, RIA

Concurrent Investment Advisors, LLC (“Concurrent”), a multi-custodial hybrid RIA, welcomes The Wealth Stewards to its growing network of aligned, independent financial advisory firms.

Key Points:

Concurrent Investment Advisors, LLC (“Concurrent”), a multi-custodial hybrid RIA, welcomes The Wealth Stewards to its growing network of aligned, independent financial advisory firms.
Jeff Breese and Brent Mekosh, managing partners of The Wealth Stewards, merged their two Arizona-based practices as part of their move to the Concurrent platform.
“Jeff and Brent are exactly the caliber of advisor we built Concurrent to support,” said Nate Lenz, CEO of Concurrent.
“The Wealth Stewards stand out because of the genuine bond between Jeff and Brent and the caliber of service they offer their clients.

dtSearch® Enhances Accessibility for "Off the Shelf" Enterprise Products and Expands Developer SDK to Cover a 5th 64-Bit Platform (Windows ARM)

Retrieved on:

torsdag, maj 2, 2024

MacOS, Metadata, Concurrency, Docker, SDK, OpenOffice, Java, ARM, PDF, Microsoft Office, VPAT, Environment, Intel, Azure, Apple, API, AWS, Organization, Computer data storage

BETHESDA, Md., May 2, 2024 /PRNewswire/ --dtSearch announces the release of version 2024.01 of its enterprise and developer product line for instantly searching terabytes of online and offline data. The product line's proprietary document filters cover popular "Office" formats, website data, databases, compression formats and emails with attachments. dtSearch products can run either "on premises" at organizations or in a cloud environment such as Azure or AWS.

Key Points:

The product line's proprietary document filters cover popular "Office" formats, website data, databases, compression formats and emails with attachments.
dtSearch products can run either "on premises" at organizations or in a cloud environment such as Azure or AWS.
The release enhances accessibility for dtSearch's main Windows "off the shelf" enterprise products, dtSearch Desktop and dtSearch Network.
dtSearch enterprise and developer products can index a terabyte of text spanning multiple folders, emails with nested attachments, online data and other databases in a single index.